Finance

Lists
002603:SHE
Shijiazhuang Yiling Pharmaceuticl Co Ltd
CNÂ¥15.42
-0.84%
(-0.13) 1D
Oct 28, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002603...
Open
CNÂ¥15.55
High
CNÂ¥15.66
Low
CNÂ¥15.36
Mkt. cap
26.50B
Avg. vol.
12.59M
Volume
12.16M
Dividend
5.19%
Quarterly dividend
CNÂ¥0.20
Ex-dividend date
Jun 16, 2026
P/E ratio
18.73
52-wk high
CNÂ¥21.58
52-wk low
CNÂ¥14.22
EPS
CNÂ¥0.82
Shares outstanding
1.67B
No. of employees
11K
Open
CNÂ¥15.55
High
CNÂ¥15.66
Low
CNÂ¥15.36
Mkt. cap
26.50B
Avg. vol.
12.59M
Volume
12.16M
Dividend
5.19%
Quarterly dividend
CNÂ¥0.20
Ex-dividend date
Jun 16, 2026
P/E ratio
18.73
52-wk high
CNÂ¥21.58
52-wk low
CNÂ¥14.22
EPS
CNÂ¥0.82
Shares outstanding
1.67B
No. of employees
11K
News stories
From web sources and news partners
About Shijiazhuang Yiling Pharmaceuticl Co Ltd
CEO-
Employees11.3K
FoundedJun 16, 1992
Headquarters-
SectorPharmaceutical industry
Websiteyiling.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.83B
1.96B
2.44B
1.63B
Cost of goods sold
659.61M
558.68M
974.60M
546.30M
Cost of revenue
659.61M
558.68M
974.60M
546.30M
Research and development expenses
185.73M
174.24M
173.79M
126.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
564.05M
748.27M
749.37M
538.30M
Operating expense
775.61M
965.99M
972.94M
692.33M
Total operating expenses
1.44B
1.52B
1.95B
1.24B
Operating income
392.23M
438.46M
492.24M
396.34M
Other non operating income
-2.04M
-1.72M
-2.14M
-892.55K
EBT including unusual items
365.98M
421.98M
489.10M
422.27M
EBT excluding unusual items
391.80M
437.85M
494.81M
400.21M
Income tax expense
34.61M
136.92M
80.49M
73.81M
Effective tax rate
9.46%
32.45%
16.46%
17.48%
Other operating expenses
30.07M
28.77M
42.45M
31.47M
Net income
331.87M
286.07M
408.85M
348.45M
Net profit margin
18.16%
14.57%
16.76%
21.31%
Earnings per share
-
-
-
-
Interest and investment income
1.81M
3.33M
5.07M
7.59M
Interest expense
-358.83K
-302.73K
-361.45K
-212.85K
Net interest expenses
1.45M
3.03M
4.71M
7.38M
Depreciation and amortization charges
-
-
-
-
EBITDA
542.37M
592.20M
645.98M
556.92M
Gain or loss from assets sale
14.19K
887.25K
-
362.77K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps